These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16215395)

  • 1. Prevention and control of antimicrobial-resistant infections in intensive care patients.
    Salgado CD; O'Grady N; Farr BM
    Crit Care Med; 2005 Oct; 33(10):2373-82. PubMed ID: 16215395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlling healthcare-associated infections: the role of infection control and antimicrobial use practices.
    Jarvis WR
    Semin Pediatr Infect Dis; 2004 Jan; 15(1):30-40. PubMed ID: 15175993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of infections caused by drug-resistant organisms in critical care.
    Hoppe B
    Am J Crit Care; 1997 Mar; 6(2):141-4. PubMed ID: 9172851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlling antibiotic-resistant bacteria: what's an intensivist to do?
    Weinstein RA; Bonten MJ
    Crit Care Med; 2005 Oct; 33(10):2446-7. PubMed ID: 16215421
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibiotic resistance in the intensive care unit.
    Kollef MH; Fraser VJ
    Ann Intern Med; 2001 Feb; 134(4):298-314. PubMed ID: 11182841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing antimicrobial-resistant bacterial infections among older adults in long-term care facilities.
    Richards CL
    J Am Med Dir Assoc; 2005; 6(2):144-51. PubMed ID: 15871891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vital Signs: Preventing Antibiotic-Resistant Infections in Hospitals - United States, 2014.
    Weiner LM; Fridkin SK; Aponte-Torres Z; Avery L; Coffin N; Dudeck MA; Edwards JR; Jernigan JA; Konnor R; Soe MM; Peterson K; McDonald LC
    MMWR Morb Mortal Wkly Rep; 2016 Mar; 65(9):235-41. PubMed ID: 26963489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic-resistant infections in the critically ill adult.
    Silveira F; Fujitani S; Paterson DL
    Clin Lab Med; 2004 Jun; 24(2):329-41. PubMed ID: 15177843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [How to limit cross-transmission of bacteria].
    Rev Prat; 2012 Sep; 62(7):981-4. PubMed ID: 23236875
    [No Abstract]   [Full Text] [Related]  

  • 10. Why is an infection control program needed in the hemodialysis setting?
    Arduino MJ; Tokars JI
    Nephrol News Issues; 2005 Jun; 19(7):44, 46-9. PubMed ID: 16008023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation precautions for antibiotic-resistant bacteria in healthcare settings.
    Gasink LB; Brennan PJ
    Curr Opin Infect Dis; 2009 Aug; 22(4):339-44. PubMed ID: 19461513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic heterogeneity optimizes antimicrobial prescription and enables resistant pathogen control in the intensive care unit.
    Piper GL; Kaplan LJ
    Surg Infect (Larchmt); 2012 Aug; 13(4):194-202. PubMed ID: 22913313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial-resistant bacteria in long-term care facilities: infection control considerations.
    Richards CL; Steele L
    J Am Med Dir Assoc; 2003; 4(3 Suppl):S110-4. PubMed ID: 12854983
    [No Abstract]   [Full Text] [Related]  

  • 14. Identifying antibiotic-resistant bacteria in hospitalized patients: what is the role of active-surveillance cultures?
    Sandora TJ; Dolan SA; Harbarth S; Huang SS; McAdam AJ; Milstone AM
    Clin Chem; 2013 Nov; 59(11):1556-60. PubMed ID: 23616638
    [No Abstract]   [Full Text] [Related]  

  • 15. An integrative review of infection prevention and control programs for multidrug-resistant organisms in acute care hospitals: a socio-ecological perspective.
    Backman C; Taylor G; Sales A; Marck PB
    Am J Infect Control; 2011 Jun; 39(5):368-378. PubMed ID: 21429622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing drug-resistant infections in health care.
    Furlow B
    Radiol Technol; 2009; 80(3):217-37. PubMed ID: 19153199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vital Signs: Estimated Effects of a Coordinated Approach for Action to Reduce Antibiotic-Resistant Infections in Health Care Facilities - United States.
    Slayton RB; Toth D; Lee BY; Tanner W; Bartsch SM; Khader K; Wong K; Brown K; McKinnell JA; Ray W; Miller LG; Rubin M; Kim DS; Adler F; Cao C; Avery L; Stone NT; Kallen A; Samore M; Huang SS; Fridkin S; Jernigan JA
    MMWR Morb Mortal Wkly Rep; 2015 Aug; 64(30):826-31. PubMed ID: 26247436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis.
    Daneman N; Sarwar S; Fowler RA; Cuthbertson BH;
    Lancet Infect Dis; 2013 Apr; 13(4):328-41. PubMed ID: 23352693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational use of antibiotics in the intensive care unit: impact on microbial resistance and costs.
    Geissler A; Gerbeaux P; Granier I; Blanc P; Facon K; Durand-Gasselin J
    Intensive Care Med; 2003 Jan; 29(1):49-54. PubMed ID: 12528022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative effects of barrier precautions and topical antibiotics on nosocomial bacterial transmission: results of multi-compartment models.
    Boldin B; Bonten MJ; Diekmann O
    Bull Math Biol; 2007 Oct; 69(7):2227-48. PubMed ID: 17453305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.